Aequus Pharmaceuticals

(OTC) AQSZF

Current Price$0.00

Market Cap$344.80K

Since IPO (2015)-99%

5 Year-98%

1 Year-35%

1 Month+420%

Aequus Pharmaceuticals Financials at a Glance

Market Cap

$344.80K

Revenue (TTM)

CA$918.47K

Net Income (TTM)

-CA$656.34K

EPS (TTM)

-$0.00

P/E Ratio

-0.76

Dividend

$0.00

Beta (Volatility)

-6.73 (Low)

Dividend

$0.00

Beta (Volatility)

-6.73 (Low)

Price

$0.00

Volume

4,300

Open

$0.00

Price

$0.00

Volume

4,300

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

Jun 15, 2026

Dividend

$0.00

Beta (Volatility)

-6.73 (Low)

Price

$0.00

Volume

4,300

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

Jun 15, 2026

AQSZF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Aequus Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Douglas Glen Janzen

Website

www.aequuspharma.ca

Headquarters

Vancouver, BC V6C 1S4, CA

AQSZF Financials

Key Financial Metrics (TTM)

Gross Margin

53%

Operating Margin

-62%

Net Income Margin

-71%

Return on Equity

Return on Capital

Return on Assets

-3%

Earnings Yield

-1.32%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$344.80K

Shares Outstanding

132.63M

Volume

4.30K

Avg. Volume

244.68K

Financials (TTM)

Gross Profit

CA$332.30K

Operating Income

-CA$2.13M

EBITDA

-CA$1.79M

Operating Cash Flow

-CA$1.66M

Capital Expenditure

CA$0.00

Free Cash Flow

-CA$1.66M

Cash & ST Invst.

CA$50.24K

Total Debt

CA$6.61M

Aequus Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q3 2025YOY CHG

Revenue

CA$251.75K

+69.7%

Gross Profit

CA$132.07K

+75.1%

Gross Margin

52.46%

N/A

Market Cap

$344.80K

N/A

Market Cap/Employee

$28.73K

N/A

Employees

N/A

Net Income

CA$370.48K

+160.3%

EBITDA

CA$308.31K

+160.0%

Quarterly Fundamentals

Name

Q3 2025YOY CHG

Total Cash

CA$9.95K

-60.8%

Total Debt

CA$4.33M

-33.8%

Accounts Receivable

CA$165.75K

+154.1%

Inventory

CA$3.54K

-96.4%

Long Term Debt

CA$0.00

-100.0%

Short Term Debt

CA$4.33M

-28.4%

Return on Assets

-3.35%

N/A

Return on Invested Capital

8.33%

N/A

Free Cash Flow

-CA$21.22K

+93.9%

Operating Cash Flow

-CA$21.22K

+93.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

HPMMHemp Naturals, Inc.

HPMMHemp Naturals, Inc.$0.00+0.00%

DVLPGolden Developing Solutions, Inc.

DVLPGolden Developing Solutions, Inc.$0.00+0.00%

TOMDFTodos Medical Ltd.

TOMDFTodos Medical Ltd.$0.00+0.00%

BIOAFBioasis Technologies Inc.

BIOAFBioasis Technologies Inc.$0.00+0.00%

NXENNexien BioPharma, Inc.

NXENNexien BioPharma, Inc.$0.00+0.00%

SHWZMedicine Man Technologies, Inc.

SHWZMedicine Man Technologies, Inc.$0.00+0.00%

NEPTFNeptune Wellness Solutions Inc.

NEPTFNeptune Wellness Solutions Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

RKLBRocket Lab

RKLBRocket Lab$102.39-0.11%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

ONDSOndas

ONDSOndas$9.33-0.05%

Questions About AQSZF

What is the current price of Aequus Pharmaceuticals?

Aequus Pharmaceuticals is trading at $0.00 per share.

What is the 52-week range for Aequus Pharmaceuticals?

Over the past 52 weeks, Aequus Pharmaceuticals has traded between $0.00 and $0.01.

How much debt does Aequus Pharmaceuticals have?

As of the most recent reporting period, Aequus Pharmaceuticals reported total debt of CA$4.33M.

How much cash does Aequus Pharmaceuticals have on hand?

Aequus Pharmaceuticals reported CA$9.96K in cash and cash equivalents in its most recent financial results.

What is Aequus Pharmaceuticals’s dividend yield?

Aequus Pharmaceuticals does not currently have a dividend yield.

Aequus Pharmaceuticals

Aequus Pharmaceuticals Financials at a Glance

AQSZF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Aequus Pharmaceuticals

AQSZF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Aequus Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About AQSZF

What is the current price of Aequus Pharmaceuticals?

What is the 52-week range for Aequus Pharmaceuticals?

How much debt does Aequus Pharmaceuticals have?

How much cash does Aequus Pharmaceuticals have on hand?

What is Aequus Pharmaceuticals’s dividend yield?

Premium Investing Services